FindTrial
Sign In

Current Status of Chinese and Western medical treatment of epilepsy

Current Status of Chinese and Western medical treatment of epilepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001172
Enrollment
Unknown
Registered
2025-06-14
Start date
2025-06-15
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Control Group:Treatment of ASMs
Observation Group:Treatment of Chinese Medicine Combined with ASMs

Sponsors

Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1) No restrictions age; 2) Meet the ILAE 2017 diagnostic criteria; 3) Received regular treatment with combined traditional Chinese medicine and conventional ASMs or conventional ASMs alone in the past three months; 4) Agree to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients with a history of drug abuse or poor medication adherence

Design outcomes

Primary

MeasureTime frame
Proportion of Epilepsy Treatment Methods (%);—

Secondary

MeasureTime frame
Average Duration per Seizure;Variations in Seizure Frequency Over 28 Days;Abnormal EEG Rate (%);Quality of Life Assessment (e.g. QOLIE-31 Scale);Seizure Severity Score;—

Countries

China

Contacts

Public ContactLiang Yu

Sichuan Provincial People's Hospital

18981838653@163.com18981838653

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026